Hepatitis: all 3,372 studies
Page 33 of 34. Open to participants first (195), then studies with results posted, then the rest; newest registration first within each.
- PEG-Interferon a-2b + Ribavirin for Treatment of Patients With Chronic Hepatitis C Who Have Previously Failed to Achieve a Sustained Virologic Response Following Interferon Alfa or Interferon a-2b + Ribavirin TherapyCompletedNCT00215865Phase 3
- HRN 004- Peginterferon a-2a Plus Ribavirin for Chronic Hepatitis C Infection in HIV Infected Persons Who Have Failed to Achieve a Sustained Virologic Response Following Previous Interferon TherapyStatus unknownNCT00215839Phase 3
- Study of the Role of Dendritic Cells in the Recurrence of Hepatitis C After Liver Transplantation. Analysis of Hepatitis C Virus (HCV) Quasispecies Evolution.Status unknownNCT00213707
- Hepatitis C Treatment of InmatesTerminatedNCT00209898Phase 4
- Plasma Ribavirin Assay During Combination Therapy for Chronic Hepatitis CTerminatedNCT00209755Not applicable
- Paroxetine for the Treatment of Interferon Related Side Effects for Hepatitis CCompletedNCT00209118Not applicable
- Infergen, Ribavirin & Avandia in Previous Relapsers or Nonresponders to Pegylated Interferon and RibavirinCompletedNCT00207402Phase 4
- Does Induction PEG-Intron in Combination With Rebetol Enhance the Sustained Response Rates in Patients With CHCCompletedNCT00207363Phase 4
- Study for the Treatment of Significant Steatosis With Xenical Followed by Treatment of Hepatitis C With Pegasys/CopegusCompletedNCT00207311Phase 4
- Impact of Moderate Alcohol Use on Hepatitis C Virus (HCV) ProgressionCompletedNCT00205075
- Pegylated Interferon Plus Ribavirin in the Treatment of Active and Past Intravenous Drug Users Infected With Hepatitis CCompletedNCT00203606Phase 4
- Case Control Study of Non Viral Hepatitis Relating to Herbal Drug Use in the Emergency DepartmentStatus unknownNCT00201578
- A Randomized Study in Non-Hodgkin's Lymphoma Patients Carrying Hepatitis B Surface AntigenCompletedNCT00201318Phase 2
- Treatment of Alcohol-Related Hepatitis With ArginineWithdrawnNCT00200746Phase 2
- Evaluation of cccDNA and Total HBV DNA Kinetics in Lymphocytes, Total Blood and Serum in Chronic Hepatitis B Patients Treated With Adefovir Dipivoxil and Peg Interferon Alpha 2aCompletedNCT00199732
- Lot-to-lot Consistency of Tritanrix™-HepB/Hib-MenAC & Its Non-inferiority vs Tritanrix™-HepB/Hiberix™ in InfantsCompletedNCT00197275Phase 3
- Comparative Study in Healthy Adults Aged 18-50 Yrs Administered With Hepatyrix or Havrix+Typherix or Tiphim Vi, to Compare Reactogenicity & ImmunogenicityCompletedNCT00197249Phase 3
- Long Term F/U Studies at Y5&6 to Demonstrate the Equivalence of 2 Vaccination Schedules of Combined Hepatitis A & B VaccineCompletedNCT00197171Phase 3
- Comparison of Monodose and Multidose Presentations of GSK Biologicals' Hepatitis B Vaccine in Terms of Immune ResponseCompletedNCT00197158Phase 4
- Efficacy of Paroxetine in the Prevention of Depressive Syndrome in Patients With Chronic Hepatitis C Treated by PEG-Interferon Alfa Plus RibavirinCompletedNCT00196664Phase 3
- Efficacy and Safety of Addition of IL-2 to Pegylated Interferon Alpha 2a and Ribavirin in HIV/HCV Coinfected PatientsCompletedNCT00196586Phase 2
- Treatment of Anemia and Neutropenia in HIV/HCV Coinfected Patients Treated With Pegylated Interferon and RibavirinTerminatedNCT00194857Phase 4
- Treatment of Acute Hepatitis C Virus Infection With Pegylated Interferon in Injection Drug UsersCompletedNCT00194480Phase 4
- Tenofovir in HIV/HBV CoinfectionCompletedNCT00192595Phase 4
- Australian Trial in Acute Hepatitis CCompletedNCT00192569Phase 4
- Pioglitazone in Hepatitis CCompletedNCT00189163Phase 4
- Insulin Resistance Associated With Chronic Hepatitis C (CHC) and the Effect of Antiviral TherapyStatus unknownNCT00188240Not applicable
- Neurocognitive Functioning in Patients With Hepatitis C Pre- and Post-Treatment With Antiviral MedicationStatus unknownNCT00188201
- Natural History of Hepatitis C in Patients With Normal Liver TestsCompletedNCT00187473
- Efficacy Study of Combined Hepatitis A and Hepatitis B Vaccine to Protect Against Hepatitis B in Hemodialysis PatientsCompletedNCT00186836Phase 4
- Computer-Assisted HIV Prevention for Young Drug UsersStatus unknownNCT00182585Not applicable
- Optimizing Hepatitis B Vaccine Response Through the Use of a Topical Immune ModulatorCompletedNCT00175435Phase 1/2
- Interferon Treatment for Patients With Chronic Hepatitis C and End Stage Renal DiseaseCompletedNCT00172809Phase 4
- Antibody Response and Immune Memory 15-18 Years After HBV VaccinationStatus unknownNCT00172328Not applicable
- Long Term Immunogenicity Study of Engerix-B Vaccine in 10 Year Old Children and the Effect of Booster InjectionsCompletedNCT00169858Phase 4
- Cellular Immune Responses to Hepatitis B Virus (HBV)- Longitudinal Follow up and Natural HistoryCompletedNCT00168194
- Orthotopic Liver Transplant (OLT) Recipients With Hepatitis C Virus (HCV) Under Preemptive TreatmentWithdrawnNCT00167557Phase 4
- Immune Response to Hepatitis C VirusWithdrawnNCT00165919
- Behavioral Intervention for HIV and HCV-Uninfected Injection Drug UsersCompletedNCT00164372Phase 2/3
- Pharmacogenomics of Interferon and Ribavirin Treatment in Patients With Chronic Hepatitis C Virus InfectionStatus unknownNCT00164073
- Associations, Outcomes and Genomics of GB Virus C, Hepatitis C Virus and Human Immunodeficiency Virus InfectionTerminatedNCT00164060
- Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined TherapyCompletedNCT00162734Phase 3
- Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral HepatitisStatus unknownNCT00160940
- Orlistat (Xenical) in the Treatment of Overweight Patients With Nonalcoholic Steatohepatitis (NASH)CompletedNCT00160407Phase 4
- Observational Study of the Durability of Seroconversion Chronic HBV Patients Who Seroconverted in a Previous Gilead-Sponsored Study of ADV.CompletedNCT00158717
- Continued Access Study of Adefovir Dipivoxil (ADV) for Patients w/Chronic HBV Infection.TerminatedNCT00158704Not applicable
- Efficacy of Pegylated Interferon Alone in Egyptian Patients With Acute Hepatitis C (ANRS 1213)CompletedNCT00158522Phase 3
- Chronic Hepatitis C Treatment by Pegylated Interferon and Ribavirin in Naive Egyptian Patients (ANRS 1211)CompletedNCT00158496Phase 3
- A Study to Evaluate the Safety and Efficacy of Celgosivir in Patients With Chronic Hepatitis C Genotype 1 InfectionCompletedNCT00157534Phase 2
- Studies of Immune Responses in Patients With Chronic Hepatitis BCompletedNCT00155155
- Effect of Polymorphisms in the IL-1 Gene Complex on the Development of Chronic Hepatitis and Hepatocellular CarcinomaStatus unknownNCT00155103
- Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis CStatus unknownNCT00154869Phase 3
- Identification of Biomarkers Associated With Human Hepatocellular Carcinoma by SELDIStatus unknownNCT00154531
- Apoptosis and Hepatitis B: The Role of Apoptosis in Patients Who Are HBeAg NegativeStatus unknownNCT00152880
- Treatment of Recurrent Hepatitis C After Liver TransplantationCompletedNCT00151580Phase 3
- Peginterferon and Ribavirin on Virologic and Immunologic Parameters in Hepatitis C Mono- and Coinfected Patient (PRIVICOP)CompletedNCT00150904
- Interferon Gamma With Peg-Interferon Alpha 2a and Ribavirin in Non Responders Patients With Chronic Hepatitis CCompletedNCT00148863Phase 2
- Improving Hepatitis C Treatment in Injection Drug UsersCompletedNCT00148031Phase 4
- HEPMET-1: Evaluate the Feasibility, Mental Sideeffects and the Efficacy of Hepatitis C Treatment in a MMT Group.CompletedNCT00147784Phase 3
- Immunogenicity of Booster Hepatitis B Vaccines in Children After Liver TransplantationStatus unknownNCT00147459Not applicable
- Study on Chronic Hepatitis C Treatment With Interferon Alpha, Ribavirin and Amantadine in Naive PatientsCompletedNCT00146016Phase 3
- A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Patients With Chronic Hepatitis CCompletedNCT00144469Phase 3
- VaxTeen Hepatitis B Vaccine Booster StudyCompletedNCT00144313Phase 4
- Multicenter Study Evaluating 12 Versus 24 Weeks Therapy With Peginterferon and Ribavirin for Hepatitis C Virus (HCV) Genotype 2 or 3CompletedNCT00143000Phase 4
- Hepatitis B Vaccine Genetics: A Substudy of ATN 024 and ATN 025CompletedNCT00142740
- CPG10101 Combination Therapy For The Treatment Of Hepatitis C In Relapsed Hepatitis C Virus (HCV) SubjectsCompletedNCT00142103Phase 1
- Response to Booster Doses of Hepatitis B Vaccine in Children and AdolescentsCompletedNCT00141999
- An Open Label Study To Evaluate The Safety and Kinetics of Nelfinavir in Subjects With HIV and Hepatitis CCompletedNCT00141284Phase 4
- Lamivudine Plus Interferon Versus Lamivudine For The Treatment Of HBeAg Positive Chronic Hepatitis B Virus (HBV)CompletedNCT00140725Phase 3
- A Study to Compare the Efficacy of Hepatitis A Vaccine and Immune Globulin When Given After Exposure to Hepatitis ACompletedNCT00139139Not applicable
- Immunogenicity Study of an Inactivated Hepatitis A Vaccine in Infants and Young ChildrenCompletedNCT00139113Phase 4
- Prophylaxis of Psychiatric Symptoms During Anti-HCV TreatmentCompletedNCT00133276Phase 2/3
- Switching Therapy From Lamivudine to Telbivudine Versus Continued Lamivudine in Adults With Chronic Hepatitis BCompletedNCT00132652Phase 3
- Pegylated Interferon Therapy for Acute Hepatitis C Infection in HIV-infected PatientsCompletedNCT00132210Phase 4
- Telbivudine Versus Lamivudine in Chinese Adults With Compensated Chronic Hepatitis BCompletedNCT00131742Phase 3
- Telbivudine Versus the Combination of Telbivudine and Valtorcitabine in Patients With Chronic Hepatitis BCompletedNCT00128544Phase 2
- Study of Bavituximab in Patients With Chronic Hepatitis C Virus InfectionCompletedNCT00128271Phase 1
- Virological and Clinical Anti-Hepatitis B Virus (HBV) Efficacy of Tenofovir and Emtricitabine in Patients With HIV/HBV co-InfectionCompletedNCT00127959Phase 4
- Peginterferon Alfa-2a, Ribavirin, Amantadine/Placebo in Hepatitis C Virus (HCV)-Genotype-1-Infection (PRAMA)Status unknownNCT00127777Phase 4
- An Extension Study of Telbivudine, Lamivudine or Telbivudine Plus Lamivudine in Patients With Chronic Hepatitis BCompletedNCT00124241Phase 2
- Safety and Efficacy of the Therapeutic Vaccine GI-5005 Versus Placebo for the Treatment of Chronic Hepatitis C InfectionCompletedNCT00124215Phase 1
- Triple Therapy With Peg-Interferon Alfa-2b/Ribavirin Plus Amantadine Compared to Standard Peg-Interferon Alfa-2b/Ribavirin for Previous Hepatitis C Virus (HCV) Non RespondersTerminatedNCT00122629Phase 3
- Efficacy of Pegylated Interferon on Liver Fibrosis in Co-infected Patient With HIV and Hepatitis CCompletedNCT00122616Phase 3
- Valopicitabine Alone and Together With Pegylated Interferon in Patients With Chronic Hepatitis C Who Have Failed to Respond to Standard TherapyCompletedNCT00120861Phase 2
- Valopicitabine When Administered Alone and in Combination With Interferon to Treatment-Naive Patients With Hepatitis CCompletedNCT00120835Phase 1/2
- Lamivudine and Therapeutic Vaccine Evaluation in Senegalese Patients With Chronic Hepatitis B Infection (ANRS 12100 HEPADAK-2)TerminatedNCT00120796Phase 3
- Long-Term Lamivudine Therapy for Chronic Hepatitis BCompletedNCT00120354Phase 4
- Efficacy and Safety of Pentoxyphilline and Tocopherol on the Fibrosis in Patients With Chronic Hepatitis CTerminatedNCT00119119Phase 3
- A Study to Evaluate the Combination of Pegylated Interferon Alfa Plus Valopicitabine in Patients With Hepatitis CCompletedNCT00118768Phase 2
- Pegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and DeltaStatus unknownNCT00117533Phase 4
- A Study of Albuferon and Ribavirin in Interferon Naive Subjects With Chronic Hepatitis C Genotype 1CompletedNCT00115908Phase 2
- Telbivudine Versus Adefovir Dipivoxil in Adults With HBegAg-Positive, Compensated Chronic Hepatitis BCompletedNCT00115245Phase 3
- The Ribavirin Pregnancy RegistryTerminatedNCT00114712
- 48 Weeks Combination Therapy for Patients With HBeAg-negative Chronic Hepatitis B Virus (HBV) InfectionCompletedNCT00114361Phase 3
- SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis CCompletedNCT00110799Phase 2
- VISN 20: Prophylactic Treatment of Interferon-Induced Depression in Hepatitis C PatientsCompletedNCT00108563Phase 4
- Safety of and Immune Response to a Hepatitis B Virus Vaccine Given With a Booster (CpG7909 ODN) in HIV Infected and HIV Uninfected PeopleCompletedNCT00100633Phase 1/2
- Effects of Anti-HIV Therapy on Treatment for Hepatitis C in HCV/HIV Infected AdultsCompletedNCT00100581Not applicable
- A Study of Albuferon With Ribavirin in Interferon Treatment Experienced Subjects With Chronic Hepatitis CCompletedNCT00097435Phase 2
- Omega Interferon Alone or in Combination With Ribavirin in Subjects With Hepatitis CCompletedNCT00097045Phase 2